Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi

Journal of the American Academy of Dermatology

Volumn 45, Issue 1, 2001, Pages 77-85

  Annessi, Giorgio ^a   Cattaruzza, Maria Sofia ^a   Abeni, Damiano ^a   Baliva, Giannandrea ^b   Laurenza, Massimo ^b   Macchini, Vittorio ^b   Melchi, Franco ^b   Ruatti, Paolo ^b   Puddu, Pietro ^b   Faraggiana, Tullio ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSPLASTIC NEVUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; PRIORITY JOURNAL; STAINING; STATISTICAL ANALYSIS;

EID: 17844403984     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.114580     Document Type: Article

References (51)

1. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
2. Current status of the dysplastic melanocytic nevus
3. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi
4. Origin of familial malignant melanomas from heritable melanocytic lesions: "The B-K mole syndrome"
5. Dysplastic nevus syndrome: A phenotypic association of sporadic melanoma
6. The dysplastic nevus syndrome: Our definition
7. Acquired precursors of cutaneous malignant melanoma: The familial dysplastic nevus syndrome
8. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi
9. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects
10. Number of melanocytic nevi as a major risk for malignant melanoma
11. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma
12. Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome
13. Genetic and epidemiologic evaluation of dysplastic nevi
14. Dysplastic nevi: Markers of increased risk for melanoma
15. Dysplastic nevi as risk markers of sporadic (non-familial) melanoma: A case-control study
16. Melanoma risk in individual with clinically atypical nevi
17. Risk of cutaneous malignant melanoma in patients with "classic" atypical-mole syndrome: A case-control study
18. Risk factors for melanoma incidence in prospective follow-up: The importance of atypical (dysplastic) nevi
19. Risk factor for developing cutaneous melanoma and criteria for identifying persons at risk: Multicentric case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society
20. Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for management
21. Clinically recognized dysplastic nevi: A central risk factor for cutaneous melanoma
22. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas
23. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: A multivariate analysis
24. National Institute of Health Consensus Development Conference Statement: Precursor to malignant melanoma
25. Clinical diagnosis of dysplastic melanocytic nevi: A clinicopathologic correlation
26. Recognition and classification of clinically dysplastic nevi from photographs: A study of interobserver variation
27. The dysplastic melanocytic nevus
28. Interclinician agreement on the recognition of selected gross morphologic features of pigmented lesions. Studies of melanocytic nevi
29. Dysplastic melanocytic nevi. Normal variants or melanoma precursors?
30. Dysplastic melanocytic nevi: A reproducible histologic definition emphasizing cellular morphology
31. An exchange of views regarding the dysplastic nevus controversy
32. Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the World Health Organization Melanoma Programme
33. Histopathologic recognition and grading of dysplastic melanocytic nevi: An interobserver agreement study
34. Interobserver recognition of dysplastic nevi from a mixed group of melanocytic lesions
35. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel
36. Histologic correlations with the clinical diagnosis of dysplastic nevus
37. The dysplastic melanocytic nevus: A prevalent lesion that correlates poorly with clinical phenotype
38. Histologic atypia in clinically benign nevi
39. The efficacy of histopathologic criteria required for diagnosing dysplastic naevi
40. Dysplastic naevus: Histological criteria and their interobserver reproducibility
41. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi
42. Weighted nominal scale agreement with provision for scaled disagreement or partial credit
43. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer
44. Dysplasia, dysplastic melanocytes, dysplastic nevi, dysplastic nevus syndrome and the relation between dysplastic nevi and malignant melanoma
45. Correlation of architectural and cytoplasmatic features with nuclear atypia in atypical (dysplastic) melanocytic nevi
46. Correlation of clinical and histopathologic features in clinically atypical melanocytic nevi
47. Sensitivity and specificity of clinical criteria in the detection of histologic atypia in nevi
48. A multiobserver population-based analysis of histologic dysplasia in melanocytic nevi